Inactive Instrument

Cannonau Corp. Stock Other OTC

Equities

CNNC

US13767L1098

Other Specialty Retailers

Financials (USD)

Sales 2022	0	Sales 2023	-	Capitalization	3.63M
Net income 2022	-	Net income 2023	-	EV / Sales 2022	23,801,577,093 x
Net Debt 2022	330K	Net cash position 2023 *	-	EV / Sales 2023	-
P/E ratio 2022	-56.3 x	P/E ratio 2023	10.8 x	Employees	-
Yield 2022 *	-	Yield 2023	-	Free-Float	9%

More Fundamentals * Assessed data

Chart Cannonau Corp.

Duration

Period

Style

Dynamic Chart

Latest news about Cannonau Corp.

Cannonau Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 12	CI
Cannonau Corp. Announces Resignation of Carmen J. Carbona as Director, President, Secretary and Treasurer	Nov. 17	CI
Cannonau Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Cannonau Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21	CI
Cannonau Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Cannonau Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-03	CI
Cannonau Corp. Auditor Raises 'Going Concern' Doubt	23-03-02	CI
Cannonau Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Cannonau Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Cannonau Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-07-08	CI
Cannonau Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-05-06	CI
Cannonau Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-12-10	CI
Cannonau Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-09-27	CI
Cannonau Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-24	CI
Virtual Medical International, Inc. Signs Distribution Agreement with Cannonau Corporation	21-05-07	CI

More news

Press releases Cannonau Corp.

CANNONAU CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-03-03	AQ
CANNONAU CORP. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	23-01-25	AQ
*Management's Discussion and Analysis of Financial Condition and Item 2 Results of Operations 14	22-11-14	AQ
*Management's Discussion and Analysis of Financial Condition and Item 2 Results of Operations 14	22-08-11	AQ
*Management's Discussion and Analysis of Financial Condition and Item 2 Results of Operations 15	22-07-19	AQ

More press releases

Managers and Directors - Cannonau Corp.

Managers	Title	Age	Since
Markwin Maring CEO	Chief Executive Officer	54	23-10-22

Members of the board	Title	Age	Since
Markwin Maring CEO	Chief Executive Officer	54	23-10-22

More insiders

Company Profile

Cannonau Corp. is engaged in offering a range of cannabidiol (CBD) products. The Company uses nanotechnology plans to offer the advanced CBD for improved bioavailability and benefit.

Sector

Other Specialty Retailers

More about the company

Sector Other Miscellaneous Specialty Retailers

	1st Jan change	Capi.
TRACTOR SUPPLY COMPANY	+23.36%	28.63B
JARIR MARKETING COMPANY	-11.42%	4.42B
JUMBO S.A.	+13.61%	4.16B
GRUPO GIGANTE, S. A. B. DE C. V.	+4.23%	1.85B
UPBOUND GROUP, INC.	-6.03%	1.74B
WINMARK CORPORATION	-12.42%	1.28B
SALLY BEAUTY HOLDINGS, INC.	-18.15%	1.14B
LESLIE'S, INC.	-42.26%	736M
MATAS A/S	-3.99%	602M

Other Miscellaneous Specialty Retailers